Phase 2 Benign Prostatic Hyperplasia Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia
Lower Urinary Track SymptomsBPH (Benign Prostatic Hyperplasia)
Beth Israel Deaconess Medical Center242 enrolled1 locationNCT06944145
Recruiting
Phase 2
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization
Prostate CarcinomaBenign Prostatic Hyperplasia
H. Lee Moffitt Cancer Center and Research Institute26 enrolled1 locationNCT04879940
Recruiting
Phase 2
Evaluation of the Functional Outcomes After Bilateral, 3D Ultrasound-guided Focal Thermal Ablation of the Prostate Transition Zone, in Patients with Benign Prostatic Hyperplasia-related Obstruction
Benign Prostatic Hyperplasia
Assistance Publique - Hôpitaux de Paris22 enrolled1 locationNCT06212453
Recruiting
Phase 2
Effects of TNF Blockade on Human BPH/LUTS
Benign Prostatic Hyperplasia (BPH)
Endeavor Health70 enrolled1 locationNCT06062875